Part 212. PART 212—CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS

• SUBPART A [§ 212.1 - § 212.5] - Subpart A—General Provisions
• SUBPART B [§ 212.10 - § 212.10] - Subpart B—Personnel and Resources
• SUBPART C [§ 212.20 - § 212.20] - Subpart C—Quality Assurance
• SUBPART D [§ 212.30 - § 212.30] - Subpart D—Facilities and Equipment
• SUBPART E [§ 212.40 - § 212.40] - Subpart E—Control of Components, Containers, and Closures
• SUBPART F [§ 212.50 - § 212.50] - Subpart F—Production and Process Controls
• SUBPART G [§ 212.60 - § 212.61] - Subpart G—Laboratory Controls
• SUBPART H [§ 212.70 - § 212.71] - Subpart H—Finished Drug Product Controls and Acceptance
• SUBPART I [§ 212.80 - § 212.80] - Subpart I—Packaging and Labeling
• SUBPART J [§ 212.90 - § 212.90] - Subpart J—Distribution
• SUBPART K [§ 212.100 - § 212.100] - Subpart K—Complaint Handling
• SUBPART L [§ 212.110 - § 212.110] - Subpart L—Records